Orchid Ventures Announces Financial Results for Period Ended March 31, 2022, Resignation of Director, and Upcoming Earnings Call
Orchid Ventures, Inc. (CSE:ORCD; OTC PINK:ORVRF) reported its Q3 2022 financial results, revealing a net loss of $421,885 on revenues of $162,602, marking a 98.6% decline in revenue compared to Q2 2022. Operational expenses decreased by 37% to $409,979. The company faced production challenges due to a Covid-related factory shutdown, impacting Q3 revenue recognition. Management is optimistic for Q4, expecting a stronger performance bolstered by new sales orders and a substantially expanded sales pipeline.
- Operational expenses decreased by 37% to $409,979.
- Management anticipates stronger revenue in Q4 due to new sales orders and backlog from Q3.
- Expanded sales pipeline with new prospects and deals in progress.
- Revenues declined by 98.6% from $478,964 in Q2 2022 to $162,602 in Q3 2022.
- Net loss increased from $413,776 in Q2 2022 to $421,885 in Q3 2022.
- Production delays due to factory shutdowns affected revenue recognition.
VANCOUVER, BC / ACCESSWIRE / May 9, 2022 / ORCHID VENTURES, INC. (CSE:ORCD);(OTC PINK:ORVRF) (the "Company" or "Orchid") announces its third quarter ("Q3 2022") financial results for the period ended March 31, 2022. All amounts expressed are in United States dollars.
| Three Months Ended March 31, 2022 | Three Months Ended Dec 31, 2021 | Variance ($) | Variance (%) | |||||||||||||
Revenues, net | $ | 162,602 | $ | 478,964 | $ | (316,362 | ) | -98.6 | % | |||||||
Cost of sales | $ | 154,924 | $ | 223,448 | $ | (68,524 | ) | -36.2 | % | |||||||
Gross profit | $ | 7,678 | $ | 255,516 | $ | (247,838 | ) | -188.3 | % | |||||||
Net expenses | $ | 402,195 | $ | 651,099 | $ | (248,904 | ) | -47.3 | % | |||||||
Loss for the period | $ | (421,885 | ) | $ | (413,776 | ) | $ | (8,109 | ) | -1.9 | % | |||||
Financial statements are prepared in accordance with International Financial Reporting Standards (IFRS). Detailed information regarding the Company's financial results as well as management's discussion and analysis can be found on its SEDAR profile at https://sedar.com/ and https://ir.orchidessentials.com/.
Management Commentary
Mr. Richard Brown, President and CFO of Orchid Ventures commented, "The 3rd quarter of FY 2022 was disappointing from the standpoint of recognized revenue, however, it was encouraging in terms of new sales orders secured. Q3 is usually more challenging in terms of getting products manufactured given that Chinese New Year runs from late January to mid February. Things were made worse this year however, as there was also an unexpected factory shutdown due to a Covid outbreak in the last 2 weeks of March, which impacted our ability to get orders out, as all shipments were delayed. The result was that revenue associated with these orders could not be recognized in Q3 and will roll over into Q4. We expect Q4 to be a stronger quarter as the company has secured additional sales to go along with the revenue that will roll over from Q3. We have also expanded our sales pipeline considerably and our sales team is currently working with a number of new prospects and on closing various deals over the coming weeks and months. We continue to fine-tune our product portfolio as we work closely with our OEM partners to both improve current products and finalize testing on new products that will strengthen our competitive position. We remain optimistic that we will finish strong in FY 2022 by posting improved sales in Q4 versus previous quarterly performance. With our growing sales pipeline and more reliable product offerings our goal is to start FY 2023 strong by posting stronger growth quarter-over-quarter and delivering improved profitability.
Summary of YTD FY2022 Developments
For three months ended March 31, 2022 ("Q3 2022"), the Company reported a net loss of
Total operational expenses were
Path to Profitability
The Company has continued to focus on their strategy to build an Orchid Ecosystem that is non-cannabis touching and better focused on leveraging the Company's core strengths, capabilities and product innovations in order to better differentiate within markets and disrupt the status quo. The key pillars to the strategy involve: (1) licensing the Orchid Essentials brand in the North America and Europe, expanding the Orchid product portfolio and commercializing new product innovation; (2) diversification beyond making cannabis products to servicing the cannabis industry with differentiated and disruptive hardware delivery systems, intellectual property development and strategic opportunities; plus (3) leveraging the Company's core capabilities to provide go-to-market services like marketing, sales and retail expertise, e-commerce, plus packaging and distribution.
To support this strategy, Orchid has either fully developed or secured exclusive access to highly impactful product innovations and intellectual property for both Orchid Brands and for Purtec Delivery Systems. These two companies form a dynamic network, interacting with each other to create and exchange sustainable value for consumers and ultimately shareholders.
Orchid Brands
Based on Orchid's branding, marketing and overall Cannabis experience and operational expertise the Company will continue to create opportunities for licensing the Orchid Essentials brand in order to expand reach into new markets and build strategic partnerships with high quality and respected local operating companies in the Cannabis industry. These licensees will use their operational strength and core capabilities to penetrate new markets by leveraging the Orchid Essentials brand and portfolio of products to accelerate growth and secure market share.
PurTec Delivery Systems
PurTec Delivery Systems ("PurTec"), sells vaporizers and other delivery systems that are highly differentiated based on 4 key product imperatives: Design, Quality, Technology, and Safety. Importantly all Purtec products go through extensive quality control and durability testing, plus they are emissions tested against the strictest standards in the world, set by AFNOR for the European Union. In addition, the Company will continue to focus on driving operational efficiencies and cost control measures as the new strategic shift proceeds and begins to gain traction in terms of revenue generation and product/technology advancements. Investment will focus on People, Process and Technology to better position the Company for growth moving forward.
Outlook
Management expects that their continued commitment and execution to their strategic priorities, driven by further developing and fine-tuning their product offerings and go-to-market strategies, will place them on a consistent path to revenue and profit growth.. Efforts will continue to focus on creating differentiation with superior, high quality and safe products combined with leveraging new technologies and innovations to disrupt markets, attract more customers and build market share. The Company believes that this business model and strategy will establish a more viable and attractive option for not just consumers, but for employees and investors as well.
Effective Friday May 6, 2022, Mr. Mervyn Simchowitz will no longer be serving on the Board of Directors of Orchid Ventures, Inc. for personal reasons. We wish Mervyn the best and will remain close to him and seek his advice in the future.
Orchid Ventures Inc. Earnings Call and Shareholder Update
Date: May 11, 2022
Time: 12:00pm Noon Eastern Standard Time (EST)
Toll Free: 888-506-0062
International: 973-528-0011
Participant Access Code: 615580
Replay
Toll Free: 877-481-4010
International: 919-882-2331
Replay Passcode: 45548
ABOUT ORCHID ESSENTIALS
Orchid Essentials is a California-based cannabis innovation company that has developed a mass-market brand and loyal consumer following with its premium cannabis products and unique vape hardware delivery systems. Orchid also owns
ON BEHALF OF THE BOARD OF DIRECTORS - ORCHID VENTURES, INC.
Corey Mangold
CEO and Chairman
investors@orchidessentials.com
Investor Relations
Corey Mangold
949-357-5818
corey@orchidessentials.com
The CSE does not accept responsibility for the adequacy or accuracy of this release.
Safe Harbor Statement
Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Orchid Ventures, Inc. and Orchid Essentials any of its affiliates or subsidiaries (collectively, the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's Canadian securities regulatory filings with sedar.com, Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's Canadian securities regulatory filings with sedar.com. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE: Orchid Ventures, Inc.
View source version on accesswire.com:
https://www.accesswire.com/700692/Orchid-Ventures-Announces-Financial-Results-for-Period-Ended-March-31-2022-Resignation-of-Director-and-Upcoming-Earnings-Call
FAQ
What were Orchid Ventures' revenues in Q3 2022?
What is Orchid Ventures' net loss for Q3 2022?
How did Orchid Ventures' Q3 2022 results compare to Q2 2022?
What challenges did Orchid Ventures face in Q3 2022?
What is the outlook for Orchid Ventures in Q4 2022?
